Both the Infection Status and Inflammatory Microenvironment Induce Transcriptional Remodeling in Macrophages in Murine Leishmanial Lesions
Journal of Parasitology · 02.06.2023 · 109 (3) · 200-210
DOI: 10.1645/22-94 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Parasitology, erschienen am 02.06.2023. Verfasst von Gopinath Venugopal und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205. Hauptthemen laut MEDLINE: Leishmania, Leishmaniasis, Cutaneous. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Cutaneous leishmaniasis is caused by infection with the protozoan parasite Leishmania, which resides intracellularly in dermal macrophages (Mø), producing lesions. The skin lesions are characterized by proinflammatory cytokines and growth factors as well as inflammatory hypoxia, creating a stressful microenvironment for Mø. Of importance, not all Mø in lesions harbor parasites. To distinguish the influence of the parasite from the inflammatory microenvironment after Leishmania major (LM) infection on the Mø, we performed single-cell RNA sequencing and compared Mø associated with LM transcripts (or ‘infected’ Mø) with Mø not associated with LM transcripts (or ‘bystander’ Mø) within the lesions. Our findings show coordinated lysosomal expression and regulation signaling with increased cathepsin and H+-ATPase transcripts are upregulated in infected compared with bystander Mø. Additionally, eukaryotic initiation factor 2 (EIF2) signaling is downregulated in infected compared with bystander Mø, which includes many small and large ribosomal subunit (Rps and Rpl) transcripts being decreased in Mø harboring parasites. Furthermore, we also find EIF2 signaling including EIF, Rps, and Rpl transcripts being downregulated in bystander Mø compared with Mø from naïve skin. These data suggest that both the parasite and the inflammatory host microenvironment affect the transcription of ribosomal machinery in lesional Mø, thereby potentially affecting the ability of these cells to perform translation, protein synthesis, and thus function. Altogether, these results suggest that both the parasite and host inflammatory microenvironment independently drive transcriptional remodeling in Mø during LM infection in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205.
- Department of Biochemistry and Molecular Biology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205.
- Arkansas Children's Research Institute, Little Rock, Arkansas 72202.
ORCID-Profile: Tiffany Weinkopff
Förderung
- NIGMS NIH HHS
- NCATS NIH HHS
Zitieren
APA
Venugopal, G., Bird, J. T., Roys, H., Bowlin, A., Fry, L., Byrum, S. D., & Weinkopff, T. (2023). Both the Infection Status and Inflammatory Microenvironment Induce Transcriptional Remodeling in Macrophages in Murine Leishmanial Lesions. Journal of Parasitology, 109(3), 200-210. https://doi.org/10.1645/22-94
Vancouver
Venugopal G, Bird JT, Roys H, Bowlin A, Fry L, Byrum SD, et al. Both the Infection Status and Inflammatory Microenvironment Induce Transcriptional Remodeling in Macrophages in Murine Leishmanial Lesions. Journal of Parasitology. 2023;109(3):200-210. doi:10.1645/22-94
BibTeX
@article{Venugopal2023,
author = {Venugopal, Gopinath and Bird, Jordan T and Roys, Hayden and Bowlin, Anne and Fry, Lucy and Byrum, Stephanie D and Weinkopff, Tiffany},
title = {Both the Infection Status and Inflammatory Microenvironment Induce Transcriptional Remodeling in Macrophages in Murine Leishmanial Lesions},
journal = {Journal of Parasitology},
year = {2023},
volume = {109},
number = {3},
pages = {200--210},
doi = {10.1645/22-94}
}
EUVIMED